---
title: "301111.SZ (301111.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301111.SZ/news.md"
symbol: "301111.SZ"
name: "301111.SZ"
parent: "https://longbridge.com/en/quote/301111.SZ.md"
datetime: "2026-03-09T07:10:37.319Z"
locales:
  - [en](https://longbridge.com/en/quote/301111.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301111.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301111.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301111.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301111.SZ/news.md)


# 301111.SZ (301111.SZ) — Related News

### [The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%](https://longbridge.com/en/news/275063436.md)
*2026-02-06T08:24:36.000Z*
> Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio

### [](https://longbridge.com/en/news/275055771.md)
*2026-02-06T01:27:03.000Z*
> Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio

### [Eight departments issued a heavy document! The Chinese medicine sector exploded, Zhendong Pharmacy surged over 19%, TY PHAR. and Hansen Pharmaceutical hit the daily limit](https://longbridge.com/en/news/275061561.md)
*2026-02-06T02:27:17.000Z*
> The Chinese medicine sector surged against the trend in the morning session, with Zhendong Pharmacy rising over 19%, and

### [LSPG: The preliminary inquiry transfer price is set at RMB 18.80 per share](https://longbridge.com/en/news/274786520.md)
*2026-02-04T09:16:04.000Z*
> LSPG disclosed the pricing situation for the shareholder inquiry transfer, with a preliminary transfer price set at RMB 

### [](https://longbridge.com/en/news/273918936.md)
*2026-01-28T02:06:43.000Z*
> The A-share innovative drug concept is partially active, with Cosunter rising over 12%, LSPG, Sunshine Guojian Pharmaceu

### [](https://longbridge.com/en/news/273635548.md)
*2026-01-26T02:03:23.000Z*
> The A-share pharmaceutical concept is active against the trend, with TY PHAR. hitting the daily limit, LKPC approaching 

### [LSPG expects a pre-loss, with an estimated net loss of 2 million to 4 million yuan for the fiscal year 2025](https://longbridge.com/en/news/273201935.md)
*2026-01-21T09:03:33.000Z*
> LSPG expects a net loss of RMB 2 million to RMB 4 million for the fiscal year 2025, with a net loss of RMB 15 million to

### [LSPG: Hehe Investment reduced its holdings by 2.1839 million shares on December 3rd-4th](https://longbridge.com/en/news/268749472.md)
*2025-12-05T11:27:02.000Z*
> 36Kr learned that LSPG announced that the company's shareholder Hehe Investment will reduce its holdings of 2.1839 milli

### [The concept of anti-influenza rebounds with fluctuations, NEPTUNUS has 7 consecutive limit-ups](https://longbridge.com/en/news/268524145.md)
*2025-12-04T02:52:42.000Z*
> The anti-influenza concept fluctuated and rebounded during the session, NEPTUNUS had 7 consecutive limit-ups, WHYY reach